STEMCELL Technologies has introduced a new benchtop instrument designed to automate the process of tissue dissociation, a critical step in preparing tissue samples for cellular research.
The device, called the STEMprep™ Tissue Dissociator System, aims to reduce the time and variability typically associated with the manual breakdown of solid tissues into single-cell suspensions, an essential procedure in fields such as cancer research and immunology. The system allows researchers to either use pre-validated protocols or customize settings depending on tissue type and experimental needs.
Manual tissue dissociation can be labor-intensive and prone to inconsistencies, which may affect data quality. According to STEMCELL, the new system is designed to improve reproducibility and yield while maintaining cell viability and functionality.
“Tissue dissociation is incredibly important for making advancements in research fields, like cancer and immunology, yet this manual process demands significant time and effort and can lead to inconsistent results” Dr. Allen Eaves, President and CEO of STEMCELL Technologies.
The launch is part of a broader push within the life sciences sector to improve standardization and efficiency in lab workflows, particularly as research grows more complex and data-driven.